Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Raman Spectroscopy-Based Method for Pan-Cancers Early Diagnosis Supported by Deep Learning: A Prospective, Single-Arm, Multicentre Study

NCT06822413 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.

NCT NCT06822413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06822413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Raman Spectroscopy-Based Method for Pan-Cancers Early Diagnosis Supported by Deep Learning: A Prospective, Single-Arm, Multicentre Study
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2022
Completion date
July 28, 2025
Enrollment
600 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adenoma colon polyp, cancer diagnosis, cancer screening, cirrhoses, liver, colorectal cancer (crc), deep learning model, esophageal cancer, gastric cancers, gastric ulcer, liver cancer, adult, malignant tumours, normal physiology, oesophagitis, pancreatic cancer, adult, pancreatitis, precancerous conditions, raman spectroscopy